HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
SLV 308
Description
SLV-308 (SME-308) is developed by solvay which is, a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties, for the potential oral treatment of Parkinson's disease (PD), panic and depression.
No brand information found.
